findmyKOL

Jay Skyler, MD

Enriched profile

Deputy Director for Clinical Research and Academic Programs (also referenced as Chief Academic Officer), Diabetes Research Institute; Professor of Medicine, Pediatrics, & Psychology, Division of Endocrinology, Diabetes and Metabolism · Diabetes Research Institute

ORCID↗NPI↗
✓ Full profile
Region🇺🇸 Miami, FL · Southeast · United StatesSpecialtyEndocrinology, Diabetes & MetabolismFocusDiabetes Management and Research+4
Active KOLfindmyKOL type: EliteLatest publication2026Online presenceverified 2026Payments2021–2025NIH funding1985–2019

Jay Skyler is Deputy Director for Clinical Research and Academic Programs (also referenced as Chief Academic Officer), Diabetes Research Institute; Professor of Medicine, Pediatrics, & Psychology, Division of Endocrinology, Diabetes and Metabolism at Diabetes Research Institute. OpenAlex indexes 487 publications with 25,637 citations (h-index 76); ClinicalTrials.gov lists 8 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Endocrinology, Diabetes & Metabolism profiles in the findmyKOL directory.

Data verified 17 Oct 2026

Overview

Updated 18 Oct 2026

Jay Skyler, MD, is Deputy Director for Clinical Research and Academic Programs (also referenced as Chief Academic Officer), Diabetes Research Institute. The public record shows 487 publications with 25,637 citations (h-index 76), centered on Diabetes Management and Research, Diabetes and associated disorders, Pancreatic function and diabetes. It also documents an investigator role on 8 registered clinical trials, industry payments reported by 14 companies, 6 NIH-funded awards (1985–2019).

  • Most recent indexed publication: 2026 · Diabetes technology & therapeutics
  • Top research focus: Diabetes Management and Research
  • 8 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 14 companies

Generated from the cited public record · current as of 18 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Type 1 Diabetes8 trialsDiabetes Mellitus7 trialsType 2 Diabetes

Research focus

OpenAlex concept fingerprint
Diabetes Management and ResearchDiabetes and associated disordersPancreatic function and diabetesDiabetes Treatment and ManagementHyperglycemia and glycemic control in critically ill and hospitalized patients

Drugs & molecules

across trials, industry payments and publications
Kerendiageneric · FinerenoneClinical trials—Industry payments23Publications1Tzieldgeneric · TeplizumabClinical trials—Industry payments11Publications1Toujeogeneric · Insulin glargineClinical trials—Industry payments14Publications—SOLIQUA 100Clinical trials—Industry payments5Publications—Non-CoveredClinical trials—Industry payments2Publications—Farxigageneric · DapagliflozinClinical trials—Industry payments1Publications—

Works with

trial sponsors and companies reporting payments
Sanofi-Aventis U.S. LLCClinical trials—Industry payments29Bayer HealthCare Pharmaceuticals Inc.Clinical trials—Industry payments25Dexcom, Inc.Clinical trials—Industry payments18Novo Nordisk ASClinical trials—Industry payments12Sanofi Us Services Inc.Clinical trials—Industry payments7Vertex Pharmaceuticals IncorporatedClinical trials—Industry payments7National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Clinical trials6Industry payments—Genzyme CorporationClinical trials—Industry payments5Novo Nordisk IncClinical trials—Industry payments4Eli Lilly and CompanyClinical trials—Industry payments2Abbvie Inc.Clinical trials—Industry payments1AstraZeneca Pharmaceuticals LPClinical trials—Industry payments1Jaeb Center for Health ResearchClinical trials1Industry payments—Jay S. SkylerClinical trials1Industry payments—Lifescan, Inc.Clinical trials—Industry payments1

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
487publications

Distinct works indexed by OpenAlex, matched via ORCID; 26 in PubMed.

25,637citations

Total citations across indexed works.

76h-index

Hirsch index (OpenAlex). i10-index 228.

Clinical & industry

trials, payments and federal funding
8clinical trials

Investigator role on registered studies.

View trials ↓
14companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
6NIH grants · 1985–2019

Federally funded research awards.

View funding ↓

Public positions

sourced statements on record

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 18 Oct 2026

Listed as an investigator on 8 registered studies on ClinicalTrials.gov. The most recent:

All 8 trial records: search, sort and filter.Explore →

Industry payments

Updated 18 Oct 2026

14 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

All 27 payment records: search, sort and filter.Explore →
View the CMS Open Payments record ↗

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    54.8%
    Statin54.8%
    Atorvastatin Calcium100%
    Part D<11 patients

  • Hormonal (systemic)

    45.2%
    l-Thyroxine45.2%
    Levothyroxine Sodium100%
    Part D<11 patients

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

Updated 18 Oct 2026

6 NIH research awards on record, funded 1985–2019 per NIH RePORTER. The latest:

All 24 award records: search, sort and filter.Explore →

Congress activity

Updated 18 Oct 2026

18 congress contributions (2014–2025) across ADA, ASCO per OpenAlex. The most recent:

All 18 congress records: search, sort and filter.Explore →

Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.

Publications

Updated 18 Oct 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

All 26 publications: search, sort and filter.Explore →

Most-cited works

by citation count (OpenAlex)
  1. 01
    Staging Presymptomatic Type 1 Diabetes: A Scientific Statement of JDRF, the Endocrine Society, and the American Diabetes Association
    1,157 citations2015
    doi.org ↗
  2. 02
    An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes
    1,124 citations2019
    doi.org ↗
  3. 03
    Rituximab, B-Lymphocyte Depletion, and Preservation of Beta-Cell Function
    1,073 citations2009
    doi.org ↗
  4. 04
    Practical recommendations for the management of diabetes in patients with COVID-19
    993 citations2020
    doi.org ↗
  5. 05
    Intensive Glycemic Control and the Prevention of Cardiovascular Events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials
    885 citations2008
    doi.org ↗
All 487 cited works: search, sort and filter.Explore →

Network

Updated 18 Oct 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Jay M. Sosenko95Jerry P. Palmer63Carla J. Greenbaum57Kevan C. Herold54Jeffrey P. Krischer48Desmond Schatz44Heba M. Ismail39María J. Redondo30Irl B. Hirsch30Jennifer B. Marks30Emily K. Sims30Åke Lernmark29Linda A. DiMeglio29Diane K. Wherrett29Brandon M. Nathan27Neil Schneiderman26Alberto Pugliese26Stephen E. Gitelman26Laura M. Jacobsen25Mark A. Atkinson24Carmella Evans‐Molina24Lisa Rafkin23Antoinette Moran22Ingrid Libman22Darrell M. Wilson22Peter A. Gottlieb22David Cuthbertson20Brian N. Bundy19Robin Goland19David Boulware19Jeffrey L. Mahon19Henry Rodriguez19Andrea K. Steck18John M. Lachin18Michael J. Haller18Dorothy J. Becker18Lue Ping Zhao16Philip Raskin16Daniel E. Geraghty16George K. Papadopoulos16

Online presence

Updated 18 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/jay-skyler-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
  • Other

    med.miami.edu/faculty/jay-s-skyler-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.miami.edu ↗
  • ResearchGate

    researchgate.net/profile/Jay-Skyler

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗
  • LinkedIn

    linkedin.com/in/jay-skyler-031842195

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗

Mentions by others

where others cite or feature them
  • Other

    diabetesresearch.org/jay-skyler

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →diabetesresearch.org ↗
  • Other

    ir.sab.bio/board-member/jay-skyler

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ir.sab.bio ↗
  • YouTube

    youtube.com/watch

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 18 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • FRCP

    Fellow of the Royal College of Physicians, United Kingdom

    2023
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →news.med.miami.edu ↗
  • MACP

    Master of the American College of Physicians

    2005
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →diabetesresearch.org ↗
  • M.D.

    Jefferson Medical College

    1969
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.miami.edu ↗
  • B.A./B.S.

    Pennsylvania State University (undergraduate)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →diabetesresearch.org ↗
  • Postgraduate training in Internal Medicine and Endocrinology & Metabolism

    Duke University Medical Center

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →en.wikipedia.org ↗

Editorial & leadership roles

journal and society appointments
  • Former Study Chairman

    NIH-sponsored Diabetes Prevention Trial-Type 1 (DPT-1) and successor Type 1 Diabetes TrialNet Clinical Trials Study Group

    2015
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.miami.edu ↗
  • Former Vice-President

    International Diabetes Federation

    2000
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →diabetesresearch.org ↗
  • Editor-in-Chief

    Diabetes Reviews

    1999
    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →en.wikipedia.org ↗
  • Former Chair

    Council of Subspecialty Societies, American College of Physicians

    1999
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →diabetesresearch.org ↗
  • Past President

    American Diabetes Association

    1991
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →diabetesresearch.org ↗
  • Founding Editor-in-Chief

    Diabetes Care

    1982
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →diabetesresearch.org ↗
  • Deputy Director for Clinical Research and Academic Programs

    Diabetes Research Institute, University of Miami

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.miami.edu ↗
  • Chief Academic Officer

    Diabetes Research Institute, University of Miami

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →diabetesresearch.org ↗
  • Professor of Medicine

    Pediatrics, & Psychology, Division of Endocrinology Diabetes & Metabolism, University of Miami Miller School of Medicine

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.miami.edu ↗
  • Member

    University of Miami Interdisciplinary Stem Cell Institute

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.miami.edu ↗
  • Chair

    Strategic Advisory Board for EDENT1FI (European action for early type 1 diabetes diagnosis)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →diabetesresearch.org ↗

Awards & honors

honors on the public record

Secondary affiliations

appointments beyond the home institution
  • Board of Directors

    SAB Biotherapeutics

    2024
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ir.sab.bio ↗
  • Former Board of Directors

    Dexcom, Inc. (NASDAQ: DXCM), 2002-2023

    2023
    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →finance.yahoo.com ↗
  • Adjunct Professor of Pediatrics

    Barbara Davis Center for Childhood Diabetes, University of Colorado Denver

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →diabetesresearch.org ↗
  • Board of Directors

    Applied Therapeutics (NASDAQ: APLT)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →appliedtherapeutics.com ↗
  • Advisor

    COUR Pharmaceuticals

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →courpharma.com ↗

Media & interviews

press, podcasts and appearances

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.